YK
Yatin Kirtanlal Desai
About Yatin Kirtanlal Desai
Data last updated:
Yatin Kirtanlal Desai is a Director at Difgen Pharmaceuticals Private Limited (since 2022) and Director at Orizo Pharma Private Limited (since 2023). The companies operate in Research & Development, Pharma and Food And Beverages. The largest current company by reported revenue is Difgen Pharmaceuticals Private Limited at ₹76.63 Cr (FY 2025). Earlier, Yatin Kirtanlal Desai was a Director at Stonefish Management Services Private Limited (2009–2015) and Director at Shree Maa Pharmachem Limited (2007–2008) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Difgen Pharmaceuticals Private Limited U72100TG2022PTC162383 | Director | 24 May 2022 | 2022 | ₹76.63 Cr (FY 2025) | Active |
| Orizo Pharma Private Limited U24290TG2022PTC158573 | Director | 24 May 2023 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Stonefish Management Services Private Limited U74140MH2009PTC189339 | Director | 05 Jan 2009 | 2009 | Active | |
| Shree Maa Pharmachem Limited U24230MH2005PLC151414 | Director | 12 Mar 2007 | 2005 | Under Liquidation | |
| Lucerne Developers Private Limited U45203MH2010PTC208644 | Director | 07 Oct 2010 | 2010 | Strike Off | |
| Trufin Consultancy Private Limited U74140MH1993PTC075754 | Director | 23 Dec 1993 | 1993 | Converted To Llp | |
| Designated Partner | 21 Feb 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Yatin Kirtanlal Desai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amol Ashok Walke | 00664315 | Difgen Pharmaceuticals Private Limited , Orizo Pharma Private Limited | Director |
| Krishna Chandrasekaran | 10243796 | Difgen Pharmaceuticals Private Limited | Director |
| Narasimhan Sridhar Nagaarjun | 10941810 | Difgen Pharmaceuticals Private Limited | Additional Director |
| Punit Chunilal Thakrar | 00351619 | Difgen Pharmaceuticals Private Limited , Orizo Pharma Private Limited | Director |
| Ramandeep Singh Jaj | 09789813 | Difgen Pharmaceuticals Private Limited | Director |
| Santhanakrishnan Srinivasan | 09789679 | Difgen Pharmaceuticals Private Limited | Director |
| Srinivasan Vedantham | 09534573 | Difgen Pharmaceuticals Private Limited | Director |
| Valiveti Brahmaji | 00079255 | Difgen Pharmaceuticals Private Limited | Additional Director |
| Vijay Kumar Vasireddy | 03262782 | Difgen Pharmaceuticals Private Limited | Director |
| Zubin Keki Gandhi | 00664632 | Difgen Pharmaceuticals Private Limited , Orizo Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yatin Kirtanlal Desai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yatin Kirtanlal Desai
Yatin Kirtanlal Desai currently holds 2 directorships: Difgen Pharmaceuticals Private Limited (Director, since 24 May 2022, revenue ₹76.63 Cr (FY 2025)); Orizo Pharma Private Limited (Director, since 24 May 2023).
Yatin Kirtanlal Desai was first appointed on 23 Dec 1993 as Director at Trufin Consultancy Private Limited. The most recent appointment on record is 24 May 2023 at Orizo Pharma Private Limited.
Yatin Kirtanlal Desai held 5 earlier board appointments: Stonefish Management Services Private Limited (Director, 05 Jan 2009 to 26 Mar 2015); Shree Maa Pharmachem Limited (Director, 12 Mar 2007 to 01 Aug 2008); Lucerne Developers Private Limited (Director, from 07 Oct 2010); Trufin Consultancy Private Limited (Director, from 23 Dec 1993); B Y & Associates Limited Liability Partnership (Designated Partner, from 21 Feb 2015).
The current boards of Yatin Kirtanlal Desai's companies include Amol Ashok Walke (Difgen Pharmaceuticals Private Limited), Krishna Chandrasekaran (Difgen Pharmaceuticals Private Limited), Narasimhan Sridhar Nagaarjun (Difgen Pharmaceuticals Private Limited), Punit Chunilal Thakrar (Difgen Pharmaceuticals Private Limited), Ramandeep Singh Jaj (Difgen Pharmaceuticals Private Limited), Santhanakrishnan Srinivasan (Difgen Pharmaceuticals Private Limited), among others.